Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenicsKenzo Yamanaka, Shoji Okada, Hirotaka Hayashi et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|1997Cited by 91
Oral Administration of Dimethylarsinic Acid, a Main Metabolite of Inorganic Arsenic, in Mice Promotes Skin Tumorigenesis Initiated by Dimethylbenz(a)anthracene with or without Ultraviolet B as a Promoter.Kenzo Yamanaka, Shoji Okada, Mutsumi Mizoi et al.|Biological and Pharmaceutical Bulletin|2001Cited by 77
The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesisKenzo Yamanaka, Shoji Okada, Fumiyo Takabayashi et al.|Toxicology and Applied Pharmacology|2004Cited by 72
The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless miceKenzo Yamanaka, Shoji Okada, Koichi Katsumata et al.|Cancer Letters|2000Cited by 66
DNA-Strand Breaks Induced by Dimethylarsinic Acid, a Metabolite of Inorganic Arsenics, Are Strongly Enhanced by Superoxide Anion Radicals.Ken RIN, Shoji Okada, Kenji Kawaguchi et al.|Biological and Pharmaceutical Bulletin|1995Cited by 51